Evidence of selective processing of immunodominant epitopes in virally infected cells

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4513-4521

  Zhang, Qian Jin ^a   Chen, Susan S ^a   Saari, Carol Ann ^a   Massuci, Maria G ^b   Tufaro, Frank ^a   Jefferies, Wilfred A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEINASE;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGENICITY; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; HERPES SIMPLEX VIRUS 1; IMMUNOGENICITY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIROGENESIS;

EID: 0034193033     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4513     Document Type: Article

References (57)

1. Neefjes, J. J., T. N. Schumacher, and H. L. Ploegh. 1991. Assembly and intracellular transport of major histocompatibility complex molecules. Curr. Opin. Cell Biol. 3:601.
2. Adorimi, L., E. Appella, G. Doria, and Z. A. Nagy. 1988. Mechanisms influencing the immunodominance of T cell determinants. J. Exp. Med. 168:2091.
3. Berzofsky, J. A. 1988. Immunodominance in T cell recognition. Immunol. Lett. 18:83.
4. Wettstein, P. J., G. M. van Bleek, and S. G. Nathenson. 1993. Differential binding of a minor histocompatibility antigen peptide to H-2 class I molecules correlates with immune responsiveness. J. Immunol. 150:2753.
5. Busch, D. H., and E. G. Pamer. 1998. MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL. J. Immunol. 160:4441.
6. Levitsky, V., Q.-J. Zhang, J. Levitskaya, and M. G. Masucci. 1996. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 183: 915.
7. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peplides presented on MHC class I molecules. Cell 78:761.
8. Roelse, J., M. Gromme, F. Momburg, G. Hammerling, and J. Neefjes. 1994. Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180:1591.
9. Snyder, H. L., J. W. Yewdell, and J. R. Bennink. 1994. Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180:2389.
10. Eisenlohr, L. C., I. Bacik, J. R. Bennink, K. Bernstein, and J. W. Yewdell. 1992. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I restricted T lymphocytes. Cell 71:963.
11. Gil-Torregrosa, B. C., A. R. Castano, and M. Del Val. 1998. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin. J. Exp. Med. 188:1105.
12. Momburg, F., J. Roelse, G. J. Hammerling, and J. J. Neefjes. 1994. Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J. Exp. Med. 179:1613.
13. Neisig, A., J. Roelse, A. J. Sijts, F. Ossendorp, M. C. Feltkamp, W. M. Kast, C. J. Melief, and J. J. Neefjes. 1995. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J. Immunol. 154:1273.
14. Frisan, T., Q. J. Zhang, J. Levitskaya, M. Coram, M. G. Kurilla, and M. G. Masucci. 1996. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells. Int. J. Cancer 68:251.
15. Neefjes, J. J., F. Momburg, and G. J. Hammerling. 1993. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter [Published erratum appears in 1994 Science 264:16.] Science 261:769.
16. Neefjes, J., E. Gottfried, J. Roelse, M. Gromme, R. Obst, G. J. Hammerling, and F. Momburg. 1995. Analysis of the fine specificity of rat, mouse and human TAP peptide transporters. Eur. J. Immunol. 25:1133.
17. Momburg, F., J. Roelse, J. C. Howard, G. W. Butcher, G. J. Hammerling, and J. J. Neefjes. 1994. Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367:648.
18. b molecule. Nature 348:213.
19. Hanke, T., F. L. Graham, K. L. Rosenthal, and D. C. Johnson. 1991. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J. Virol. 65:1177.
20. Bonneau, R. H., T. M. Fu, and S. S. Tevethia. 1993. In vivo priming and activation of memory cytotoxic T-lymphocytes (CTL) by a chimeric simian virus 40 T antigen expressing an eight amino acid residue herpes simplex virus gB CTL epitope. Virology 197:782.
21. Cantin, E. M., R. Eberle, J. L. Baldick, B. Moss, D. E. Wiley, A. L. Notkins, and H. Openshaw. 1987. Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc. Natl. Acad. Sci. USA 84:5908.
22. Witmer, L., K. L. Rosenthal, F. L. Graham, H. M. Friedman, A. Yee, and D. C. Johnson. 1990. Cytolytic T lymphocytes specific for herpes simplex virus studied using adenovirus vectors expressing HSV glycoproteins. J. Gen. Virol. 71:387.
23. Nugent, C. T., R. M. Wolcott, R. Chervenak, and S. R. Jennings. 1994. Analysis of the cytolytic T-lymphocyte response to herpes simplex virus type 1 glycoprotein B during primary and secondary infection. J. Virol. 68:7644.
24. b-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. J. Immunol. 160:3163.
25. Tufaro, F., M. D. Snider, and S. L. McKnight. 1987. Identification and characterization of a mouse cell mutant defective in the intracellular transport of glycoproteins. J. Cell Biol. 105:647.
26. Lippe, R., G. Kolaitis, C. Michaelis, F. Tufaro, and W. A. Jefferies. 1993. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk cells. J. Immunol. 150:3170.
27. Whealy, M. E., A. K. Robbins, F. Tufaro, and L. W. Enquist. 1992. A cellular function is required for pseudorabies virus envelope glycoprotein processing and virus egress. J. Virol. 66:3803.
28. Gabathuler, R., G. Reid, G. Kolaitis, J. Driscoll, and W. A. Jefferies. 1994. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J. Exp. Med. 180:1415.
29. 2-microglobulin in the intracellular transport and surface expression of murine class I histocompatibility molecules. J. Immunol. 142:2796.
30. Celis, J., B. Gesser, H. H. Rasmussen, P. Madsen, H. Leffers, K. Dejgaard, B. Honore, E. Olsen, G. Ratz, and J. B. Lauridsen. 1990. Two-dimensional gel protein databases. Electrophoresis 11:989.
31. Kvist, S., K. Wiman, L. Claesson, P. A. Peterson, and B. Dobberstein. 1982. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell 29:61.
32. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
33. Rammensee, H.-G., T. Firde, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
34. Zhang, Q. J., Y. Lindquist, V. Levitsky, and M. G. Masucci. 1996. Solvent exposed side chains of peptides bound to HLA A*1101 have similar effects on the reactivity of alloantibodies and specific TCR. Int. Immunol. 8:927.
35. Hogquist, K. A., A. G. I. Grandea, and M. J. Bevan. 1993. Peptide variants reveal how antibodies recognize major histocompatibility complex class I. Eur. J. Immunol. 23:3028.
36. Catipivic, B., P. J. Dal, M. Mage, T. E. Johansen, and J. P. Schneck. 1992. Major histocompatibility complex conformational epitopes are peptide specific. J. Exp. Med. 176:1611.
37. Shepherd, J. C., T. N. Schumacher, P. G. Ashton-Rickardt, S. Imaeda, H. L. Ploegh, C. A. J. Janeway, and S. Tonegawa. 1993. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74:577.
38. Neefjes, J. J., F. Momburg, and G. J, Hammerling. 1993. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter [Published erratum appears in 1994 Science 264:16.] Science 261:769.
39. Nandi, D., H. Jiang, and J.J. Monaco. 1996. Identification of MECL-1 (LMP-10) as the third IFN-γ-inducible proteasome subunit. J. Immunol. 156:2361.
40. Rosenthal, K. L., J. R. Smiley, S. South, and D. C. Johnson. 1987. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes. J. Virol. 61:2438.
41. Ljunggren, H. G., N. S. Stam, C. Ohlen, J. J. Neefjes, P. Hoglund, M. T. Heemels, J. Bastin, T. N. M. Schumacher, A. Townsend, K. Karre, and H. L. Ploegh. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476.
42. Chen, W., S. Khilko, J. Fecondo, D. H. Margulies, and J. McCluskey. 1994. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J. Exp. Med. 180:1471.
43. van der Burg, S. H., M. J. W. Visseren, R. M. P. Brandt, W. M. Kast, and C. J. M. Melief. 1996. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 156:3308.
44. Brooks, J. M., R. A. Colbert, J. P. Mear, A. M. Leese, and A. B. Rickinson. 1998. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex. J. Immunol. 161:5252.
45. Seliger, B., M. J. Maeurer, and S. Ferrone. 1997. TAP off - tumors on. Immunol. Today 18:257.
46. Restifo, N. P., F. Esquivel, Y. Kawakami, J. W. Yewdell, J. J. Mule, S. A, Rosenberg, and J. R. Bennink. 1993. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:265.
47. Vitale, M., R. Rezzani, L. Rodella, G. Zuali, P. Grigolato, M. Cadei, D. J. Hicklin, and S. Ferrone. 1998. HLA class 1 antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res. 58:737.
48. Khanna, R., S. R. Burrows, V. Argaet, and D. J. Moss. 1994. Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line. Int. Immunol. 6:639.
49. Schumacher, T. N., D. V. Kantesaria, M. T. Heemels, R. P. Ashton, J. C. Shepherd, K. Fruh, Y. Yang, P. A. Peterson, S. Tonegawa, and H. L. Ploegh. 1994. Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J. Exp. Med. 179:533.
50. Orlowski, M., C. Cardozo, and C. Michaud. 1993. Evidence for the presence of live distinct proleolytic components in the pituitary multicatalytic proteinase complex; properties of two components cleaving bonds on the carnoxyl side of branched chain and small neutral amino acids. Biochemistry 32:1563.
51. Djaballah, H. 1997. Antigen processing by proteasomes: insights into the molecular basis of crypticity. Mol. Biol. Rep. 24:63.
52. Dick, L. R., C. Aldrich, S. C. Jameson, C. R. Moomaw, B. C. Pramanik, C. K. Doyle, G. N. DeMartino, M. J. Bevan, J. M. Forman, and C. A. Slaughter. 1994. Proteolytic processing of ovalbumin and β-galactosidase by the proteasome to yield antigenic peptides. J. Immunol. 152:3884.
53. Snyder, H. L., I. Bacik, J. R. Bennink, G. Kearns, T. W. Behrens, T. Bachi, M. Orlowski, and J. W. Yewdell. 1997. Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing. J. Exp. Med. 186:1087.
54. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289.
55. Yang, B., Y. S. Hahn, C. S. Hahn, and T. J. Braciale. 1996. The requirement for proteasome activity in class I major histocompatibilily complex antigen presentation is dictated by the length of preprocessed antigen. J. Exp. Med. 183:1545.
56. Dick, T. P., T. Ruppert, M. Groettrup, P. M. Kloetzel, L. Kuehn, U. H. Koszinowski, S. Stevanovic, H. Schild, and H.-G. Rammensee. 1996. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86:253.
57. Stevens, J., K. H. Weismuller, P. Walder, and E. Joly. 1998. Peptide length preferences for rat and mouse MHC class I molecules using random peptide libraries. Eur. J. Immunol. 28:1272.